Stockscreener 앱 받기
1.38
4.83%
-0.07
시간 외 거래:
1.44
0.06
+4.35%
전일 마감가:
$1.45
열려 있는:
$1.43
하루 거래량:
6.61M
Relative Volume:
13.21
시가총액:
$159.59M
수익:
$232.79M
순이익/손실:
$-88.69M
주가수익비율:
-3.1229
EPS:
-0.4419
순현금흐름:
-
1주 성능:
-13.75%
1개월 성능:
-28.50%
6개월 성능:
-47.73%
1년 성능:
+0.00%
1일 변동 폭
$1.315
$1.44
1주일 범위
$1.315
$1.64
52주 변동 폭
$1.315
$5.19
Novabridge Biosciences Adr Stock (NBP) Company Profile
Compare NBP vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
1.38 | 159.59M | 232.79M | -88.69M | 0 | -0.4419 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-06 | 재개 | H.C. Wainwright | Buy |
| 2025-10-03 | 개시 | Leerink Partners | Outperform |
| 2025-09-09 | 개시 | BTIG Research | Buy |
| 2021-12-09 | 개시 | Siebert Williams Shank | Buy |
| 2021-06-02 | 개시 | Daiwa Securities | Buy |
| 2021-03-15 | 개시 | Needham | Buy |
| 2021-03-03 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-25 | 개시 | Piper Sandler | Overweight |
| 2020-12-07 | 개시 | H.C. Wainwright | Buy |
| 2020-07-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-02-12 | 개시 | China Renaissance | Buy |
| 2020-02-11 | 개시 | Jefferies | Buy |
모두보기
Novabridge Biosciences Adr 주식(NBP)의 최신 뉴스
Empowering Investor Success - Morningstar
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
Novabridge Biosciences ADR (NBP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Novabridge Biosciences ADR (NBP) Cash Flow - TradingKey
Novabridge Biosciences ADR (NBP) Institutional Confidence - TradingKey
NBP|Novabridge Biosciences ADR|Price:1.840|Chg%:+0.070 - TradingKey
Novabridge Biosciences ADR (NBP) Balance Sheet - TradingKey
Novabridge Biosciences ADR (NBP) Income Statement - TradingKey
NBP|Novabridge Biosciences ADR|Price:1.790| - TradingKey
Novabridge Biosciences ADR (NBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Novabridge Biosciences ADR (NBP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Novabridge Biosciences ADR (NBP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Novabridge Biosciences ADR (NBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NBP|Novabridge Biosciences ADR|Price:1.770| - TradingKey
Novabridge Biosciences ADR (NBP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NovaBridge Biosciences SVP sells $3,991 in ordinary shares - Investing.com
NBPNovaBridge Biosciences ADR Latest SEC Filings - Finviz
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer - Barchart.com
NovaBridge Biosciences Sponsored ADR Actuals & Estimates (NASDAQ:NBP) - TradingView
Novabridge Biosciences ADR (NBP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Novabridge Biosciences ADR - TradingKey
NovaBridge Biosciences (NBP) corrects major holder stakes in 20-F/A filing - Stock Titan
NovaBridge Biosciences stock surges on FDA Fast Track nod By Investing.com - Investing.com South Africa
NovaBridge Biosciences stock surges on FDA Fast Track nod - Investing.com
Number of shareholders of NovaBridge Biosciences Sponsored ADR – GETTEX:0VY - TradingView
NovaBridge Biosciences SVP Claire Xu sells $13,766 in shares By Investing.com - Investing.com India
NovaBridge Biosciences SVP Claire Xu sells $13,766 in shares - Investing.com
Sean Cao, NovaBridge Biosciences chief BD officer, sells $42,584 in shares - Investing.com
TradingKey - TradingKey
Alpha Buying: Insider Conviction in High-Risk Biotech - Sahm
NovaBridge Biosciences president buys $577,300 in company shares By Investing.com - Investing.com India
NovaBridge Biosciences president buys $577,300 in company shares - Investing.com
NovaBridge appoints Mark Hagler as president, chief commercial officer - Investing.com
NovaBridge Biosciences (NASDAQ: NBP) posts 2025 loss, extends cash runway to 2028 - Stock Titan
NovaBridge gets FDA nod for accelerated approval path for givastomig - Investing.com
NovaBridge reports positive Phase 2a data for eye disease drug - Investing.com
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
BTIG Sticks to Their Buy Rating for Ascentage Pharma Group International Unsponsored ADR (AAPG) - The Globe and Mail
What is the current Price Target and Forecast for NovaBridge Biosciences (NBP) - Zacks Investment Research
NovaBridge Biosciences (0VY.F) stock price, news, quote and history - Yahoo Finance Singapore
What date does NovaBridge Biosciences's (NBP) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
NBP Stock Price | Analyst Target 9.00 & Consensus - eToro
NBP Options Overview History for Novabridge Biosciences ADR Stock - Barchart.com
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
NBP: Transforming into a global biotech, rebranding, and pursuing dual NASDAQ/HKEX listing - TradingView
NBP: Jeva Stomach demonstrates high efficacy and safety, with broad expansion plans and strong financial runway - TradingView
IMAB SEC FilingsI-Mab 10-K, 10-Q, 8-K Forms - Stock Titan
NBP: Reduced net loss and accelerated givastomig progress position I-Mab for key milestones - TradingView
I-MAB American (IMAB) Stock Price, News & Analysis - Stock Titan
NBP: Lead asset givastomig shows strong efficacy and safety in gastric cancer, with key data readouts in 2024–2025 - TradingView
Novabridge Biosciences Adr (NBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):